DR info

Clinical trials : 21 / Drugs : 40 - (DrugBank : 11) / Drug target genes : 10 - Drug target pathways : 50

Marfan syndrome and other diseases between which drug repositioning (DR) might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Score (Drug repositionability)

ID	Diseases (Sorted by score)	Score
167	Marfan syndrome	-
96	Crohn disease	8.148
86	Pulmonary arterial hypertension	6.528
6	Parkinson disease	6.468
67	Polycystic kidney disease	5.287
58	Hypertrophic cardiomyopathy	5.206
70	Spinal stenosis	5.123
226	Interstitial cystitis with Hunners ulcer	3.825
97	Ulcerative colitis	3.701
13	Multiple sclerosis/Neuromyelitis optica	3.654
193	Prader-Willi syndrome	2.745
17	Multiple system atrophy	2.705
57	Idiopathic dilated cardiomyopathy	2.667
46	Malignant rheumatoid arthritis	2.568
81	Congenital adrenal hyperplasia	2.400
278	Huge lymphatic malformation with cervicofacial lesion	2.160
215	Tetralogy of Fallot	2.133
272	Fibrodysplasia ossificans progressiva	1.969
140	Dorabe syndrome	1.800
50	Dermatomyositis	1.800
144	Lennox-Gastaut syndrome	1.796
90	Retinitis pigmentosa	1.796
298	Hereditary pancreatitis	1.781
113	Muscular dystrophy	1.763
156	Rett syndrome	1.725
51	Scleroderma	1.685
169	Menkes disease	1.600
170	Occipital horn syndrome	1.600
227	Osler disease	1.174
22	Moyamoya disease	1.125
210	Single Ventricle	1.097
66	IgA nephropathy	1.080
158	Tuberous sclerosis	1.080
296	Biliary atresia	1.040
11	Myasthenia gravis	1.040
157	Sturge-Weber syndrome	1.040
222	Primary nephrotic syndrome	1.003
111	Congenital myopathy	1.000